REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$796.10
arrow_downward
-0.71%(-5.72) 1D
Sep 24, 3:51:05 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$801.59
High
$813.53
Low
$789.39
Mkt. cap
81.80B
Avg. vol.
681.10K
Volume
333.07K
Dividend
0.47%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.64
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$801.59
High
$813.53
Low
$789.39
Mkt. cap
81.80B
Avg. vol.
681.10K
Volume
333.07K
Dividend
0.47%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.64
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Simply Wall Street
·
21 hours ago
Regeneron Pharmaceuticals (REGN) Could Be 4% Undervalued Following Class Action Filing
TradingView
·
1 day ago
REGN: Robust growth and pipeline advances highlight a science-driven strategy and disciplined capital allocation
Investing.com
·
1 day ago
Regeneron at Bernstein healthcare forum: growth engines stay in focus
AD HOC NEWS
·
1 day ago
Regeneron Pharmaceuticals stock trades near its yearly high
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com